48-Hour drug may improve outcomes in preterm membrane rupture
NCT ID NCT03976063
First seen Nov 20, 2025 · Last updated Jun 11, 2026 · Updated 28 times
Summary
This study tests whether giving a short-term (48-hour) medication to stop contractions can improve survival and reduce severe health problems in babies when the water breaks early (between 22 and 34 weeks of pregnancy). About 857 pregnant people with a single baby and no signs of infection are participating. The goal is to see if this approach can safely delay delivery and lower the risk of complications like breathing difficulties or brain injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM PREMATURE RUPTURE OF MEMBRANE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Trousseau University Hospital
Paris, 75012, France
Conditions
Explore the condition pages connected to this study.